Kairos Pharma Ltd. (KAPA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.73
-0.04 (-2.26%)
At close: Jan 17, 2025, 3:59 PM
1.73
0.00%
After-hours Jan 17, 2025, 06:30 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -14.9 | -25.35 | -15.57 | -27.74 |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | -43.12 | -22.57 | -28.61 | -85.06 |
P/FCF Ratio | 333.25 | -75.39 | -81.04 | -756.74 |
P/OCF Ratio | 333.25 | -75.39 | -81.04 | -756.74 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | -0.49 | -0.33 | -0.15 |
Quick Ratio | 0.06 | 0.27 | 0.04 | 0.04 |
Current Ratio | 0.06 | 0.27 | 0.04 | 0.04 |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | -17.49 | -1.19 | -9.62 | -193.3 |
Return on Equity (ROE) | 2.89 | 0.89 | 1.84 | 3.07 |
Return on Assets (ROA) | -1.88 | -1.01 | -2.77 | -73.48 |
Return on Capital (ROIC) | 2.74 | 0.96 | 1.66 | 3.05 |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |